Optimizing treatment of HIV-associated lymphoma

A Noy - Blood, The Journal of the American Society of …, 2019 - ashpublications.org
Cancer is the leading cause of death for HIV-infected persons in economically developed
countries, even in the era of antiretroviral therapy (ART). Lymphomas remain a leading …

Has the time come for metronomics in low-income and middle-income countries?

N André, S Banavali, Y Snihur, E Pasquier - The Lancet Oncology, 2013 - thelancet.com
Summary In 2008, 72% of cancer deaths occurred in low-income and middle-income
countries, where, although there is a lower incidence of cancer than in high-income …

Meeting the challenge of hematologic malignancies in sub-Saharan Africa

S Gopal, WA Wood, SJ Lee, TC Shea… - Blood, The Journal …, 2012 - ashpublications.org
Cancer is a leading cause of death and disability in sub-Saharan Africa and will eclipse
infectious diseases within the next several decades if current trends continue. Hematologic …

HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities

L Chinula, A Moses, S Gopal - Current Opinion in HIV and AIDS, 2017 - journals.lww.com
HIV-associated malignancies in sub-Saharan Africa: progress,... : Current Opinion in HIV and
AIDS HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and …

Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial

S Kimani, MS Painschab, B Kaimila… - The Lancet Global …, 2021 - thelancet.com
Background There are no clinical trials involving patients with diffuse large B-cell lymphoma
(DLBCL) in sub-Saharan Africa since antiretroviral therapy (ART) for HIV became widely …

Treatment management of haematological malignancies in people living with HIV

A Re, C Cattaneo, S Montoto - The Lancet Haematology, 2020 - thelancet.com
Although the incidence of HIV-associated lymphomas decreased after the introduction of
effective combination antiretroviral therapy, they became the most common AIDS-related …

Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort

NCS Mezger, L Hämmerl, M Griesel… - The …, 2023 - academic.oup.com
Abstract Background Although non-Hodgkin lymphoma (NHL) is the 6th most common
malignancy in Sub-Saharan Africa (SSA), little is known about its management and …

HIV lymphoma and Burkitts lymphoma

A Noy - The Cancer Journal, 2020 - journals.lww.com
Despite widely available antiretroviral therapy, lymphoma remains the leading cause of
death for human immunodeficiency virus (HIV)–infected persons in economically developed …

CHOP chemotherapy for aggressive non-Hodgkin lymphoma with and without HIV in the antiretroviral therapy era in Malawi

S Gopal, Y Fedoriw, B Kaimila, ND Montgomery… - PLoS …, 2016 - journals.plos.org
There are no prospective studies of aggressive non-Hodgkin lymphoma (NHL) treated with
CHOP in sub-Saharan Africa. We enrolled adults with aggressive NHL in Malawi between …

Accuracy of Burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology

MD Ogwang, W Zhao, LW Ayers… - … of pathology & …, 2011 - meridian.allenpress.com
Abstract Context.—Burkitt lymphoma (BL) is endemic in Uganda and because of the high
incidence, diagnosis is often presumed during clinical care and epidemiologic studies …